Editor's Note
The Food & Drug Administration on April 16 announced it is considering additional regulatory actions, including consulting with federal health experts for guidance, to reduce the risks of contamination and infections associated with duodenoscopes.
The FDA is also working with manufacturers of disposable duodenoscopes that would make reprocessing unnecessary and on new device designs that may decrease contamination risks.
The poster presentations at the 2024 OR Manager Conference showcased…
The poster presentations at the 2024 OR Manager Conference showcased…
Health systems are fundamentally capital intensive. They are regulated; depend…